Try StemWave for up to 60 Days for $0

Electrohydraulic vs. Electromagnetic Shockwave: Understanding the Technical Differences

Electrohydraulic vs Electromagnetic Technology

Electrohydraulic and electromagnetic devices both fall under the acoustic wave therapy category, but they generate waves through fundamentally different mechanisms. Electrohydraulic technology creates waves through plasma bubble explosion (5-10 nanosecond rise time), while electromagnetic devices use magnetic vibration to focus pressure waves (8-500 nanosecond rise time according to published research). This article examines the technical distinctions, clinical applications, and what providers should consider when evaluating these technologies.

How Do Electrohydraulic and Electromagnetic Technologies Generate Waves?

Understanding wave generation helps providers evaluate which technology aligns with their clinical needs.

Electromagnetic Wave Generation

Electromagnetic devices use magnets positioned around a central point. When activated, the magnets vibrate rapidly, creating acoustic waves that converge at a focal point through constructive interference. The waves approach the target tissue from multiple angles.

According to a 2013 study examining one electromagnetic device (Duolith), the rise times measured between 8-500 nanoseconds depending on machine settings. Research categorizes these as “focused pressure waves” rather than true shockwaves based on this rise time data.

Electrohydraulic Wave Generation

Electrohydraulic technology uses an electrode submerged in water. An electrical spark creates a plasma bubble that reaches temperatures of 2,200-3,000°C (some sources cite up to 18,000°C depending on energy settings). This plasma bubble explodes, generating a shockwave with a rise time of 5-10 nanoseconds.

This meets the technical definition of a true shockwave: a supersonic acoustic wave (traveling at approximately 1,500 meters per second, or 5 times the speed of sound) with near-instantaneous pressure rise.

What Is the Difference Between Focused Pressure Waves and True Shockwaves?

The distinction isn’t just semantic. The mechanical profile of the wave determines its interaction with tissue.

Rise Time:

  • Electromagnetic: 8-500 nanoseconds
  • Electrohydraulic: 5-10 nanoseconds

Wave Velocity:

  • Electromagnetic: Creates acoustic waves through magnetic vibration
  • Electrohydraulic: 1,500 meters per second (supersonic)

Generation Method:

  • Electromagnetic: Magnetic vibration and convergence
  • Electrohydraulic: Plasma bubble explosion

Research by Jokinen and colleagues suggests categorizing these technologies as “focused pressure waves” (electromagnetic, piezoelectric) and “focused shockwaves” (electrohydraulic) to reflect these technical differences.

How Do Focal Zone Characteristics Compare?

Focal zone width affects treatment coverage and clinical application.

Electromagnetic Focal Characteristics

Electromagnetic devices achieve their advertised penetration depth (often cited as 12-12.5 cm) by concentrating energy into a narrow focal point. Published research describes focal zones typically 2-3 millimeters wide at the target depth.

This focused approach allows precise targeting but requires repositioning to cover larger treatment areas.

Electrohydraulic Focal Characteristics

Electrohydraulic devices like StemWave generate a broader focal zone, spanning several centimeters. The energy penetrates to similar depths (up to 12 cm) while covering a wider therapeutic area per application.

Most musculoskeletal conditions involve tissue pathology across centimeters rather than millimeters (rotator cuff tendons, lumbar fascia, hip tendon insertions), which may influence which focal pattern better serves clinical needs.

What Does Research Show About Biological Mechanisms?

Both technologies stimulate tissue through mechanotransduction (mechanical stimulus converted to biochemical signals). However, research indicates some biological responses may differ.

Effects Documented with Electrohydraulic Technology:

  1. Voltage-Gated Sodium Channel Blocking True shockwaves activate serotonin while reducing substance P and calcitonin gene-related peptide, inflammatory mediators released from nerve endings. This provides immediate pain relief through specific pathway interruption.
  2. Macrophage Phenotype Conversion Published research demonstrates electrohydraulic shockwaves rapidly convert M1 (inflammatory) macrophages to M2 (repair-focused) macrophages . This accelerates healing while simultaneously reducing pain.
  3. Toll-Like Receptor 3 Activation https://pubmed.ncbi.nlm.nih.gov/28122964/ , When cells are compressed at extreme speed by true shockwaves, they leak messenger RNA that activates TLR3 pathways. This recruits stem cells to the treatment area, initiating angiogenesis and tissue repair.

Effects Documented with Electromagnetic Technology:

Electromagnetic devices demonstrate beneficial tissue effects through mechanotransduction, though the specific biological pathways may differ from electrohydraulic technology. The published research on TLR3-mediated stem cell activation and rapid macrophage conversion appears specific to electrohydraulic shockwaves based on available studies.

How Do Treatment Protocols Compare?

Treatment efficiency influences practice workflow and patient experience.

Typical Electrohydraulic Protocols (StemWave)

  • Session duration: 5-8 minutes
  • Shockwaves per session: 300-500
  • Protocol length: 8-12 sessions

Electromagnetic Protocol Considerations

Session duration varies by device model and condition treated. The narrower focal zone may require more positioning adjustments to adequately cover treatment areas.

What Do Providers Report About Patient Experience?

Patient response patterns influence protocol completion and practice outcomes.

Immediate vs. Gradual Improvement

StemWave providers consistently report 10-30% measurable improvement after a single session. Patients demonstrate functional changes they can feel and verify before leaving the clinic.

This immediate response affects patient commitment. When patients experience tangible proof in session one, protocol completion rates typically increase (StemWave providers report approximately 70% consultation-to-protocol conversion rates).

Electromagnetic devices produce documented benefits, though improvement timelines may differ. Some patients experience gradual improvement accruing over multiple sessions rather than immediate measurable change.

Comparison Table: Electrohydraulic vs. Electromagnetic Technology

Factor

Electrohydraulic (StemWave)

Electromagnetic

Wave Generation

Plasma bubble explosion

Magnetic vibration/convergence

Rise Time

5-10 nanoseconds

8-500 nanoseconds (published study)

Wave Classification

True shockwave

Focused pressure wave

Focal Zone Width

Several centimeters (broad)

2-3 millimeters (narrow)

Penetration Depth

Up to 12 cm

Up to 12-12.5 cm (device-dependent)

Typical Session Duration

5-8 minutes

Varies by device/condition

Shockwaves Per Session

300-500

Varies by device/protocol

Immediate Patient Response

10-30% improvement session one

Variable, often gradual

TLR3 Stem Cell Activation

Documented in research

Not documented in available research

Rapid Macrophage Conversion

Documented in research

Not documented in available research


What Clinical Support Accompanies Each Technology?

Technology effectiveness depends partly on implementation support.

StemWave Support System

  • Structured clinical onboarding 
  • Marketing templates (email, social media, consultation scripts)
  • Live coaching programs with six-figure service line providers
  • Community of 750+ providers sharing protocols and outcomes
  • Ongoing clinical and business support

Electromagnetic Support

Support varies by manufacturer and distributor. Providers considering electromagnetic devices should investigate specific training, protocols, and ongoing support availability.

What Should Providers Consider When Evaluating Technologies?

Rather than declaring one technology “better,” providers should assess alignment with specific practice needs:

Consider Electrohydraulic (StemWave) If:

  • Immediate patient response is important for conversion/retention
  • Treatment efficiency (5-8 minute sessions) matters for workflow
  • Broader focal zone suits your typical case presentations
  • True shockwave biological mechanisms are clinically relevant
  • Comprehensive support system is valuable
  • You want technology with documented TLR3 and macrophage research

Consider Electromagnetic If:

  • Precise focal targeting suits your treatment approach
  • You’re already familiar with electromagnetic protocols
  • Your distributor provides strong ongoing support
  • Device cost and maintenance align with practice financials
  • You have clinical experience with this technology

FAQ: Electrohydraulic vs. Electromagnetic Devices

Are electromagnetic devices truly “shockwave” technology?

Published research (including the 2013 Duolith study) indicates electromagnetic devices generate “focused pressure waves” with rise times of 8-500 nanoseconds. True shockwaves require 5-10 nanosecond rise times. Both technologies produce beneficial clinical effects through different mechanical mechanisms.

Which technology has stronger research support?

Electrohydraulic technology has decades of research as the original form of extracorporeal shockwave therapy, with specific documentation of TLR3 activation and macrophage conversion. Electromagnetic technology has growing clinical evidence but less extensive publication history for these specific biological pathways.

Will patients notice differences between technologies?

Patient experience may differ. Electrohydraulic providers typically report 10-30% improvement patients can immediately feel and demonstrate, which affects protocol completion rates. Electromagnetic improvement timelines vary but may be more gradual.

How do long-term outcomes compare?

Both technologies can produce lasting results when protocols are completed properly. The differences lie more in treatment efficiency, immediate patient response, and the specific biological pathways activated.

What about device reliability and maintenance?

Both technologies require maintenance. Electrohydraulic devices need electrode replacement periodically. Electromagnetic maintenance varies by model. Providers should factor ongoing maintenance costs and complexity into purchase decisions.

The Bottom Line

Electrohydraulic and electromagnetic technologies both serve musculoskeletal treatment needs, but through different physical and biological mechanisms. The key distinctions are:

  • Wave generation: Explosion vs. magnetic vibration
  • Rise time: 5-10 ns vs. 8-500 ns
  • Focal characteristics: Broad zone vs. narrow focal point
  • Biological research: TLR3/macrophage effects documented specifically with electrohydraulic
  • Patient response timeline: Immediate measurable vs. often gradual
  • Treatment efficiency: Time and shockwave count differences

Rather than asking “which is better,” providers should ask “which better serves my patient population, practice workflow, and clinical goals?”

For practices prioritizing immediate patient response, treatment efficiency, and the biological mechanisms documented with true shockwaves, electrohydraulic technology offers distinct advantages.

That’s where StemWave comes in.

Learn more about StemWave

Disclosure Statement: The content provided in this blog post is for informational purposes only and should not be considered medical advice. The opinions expressed are based on publicly available research and clinical experience. StemWave is a Class I medical device, and individual results may vary. This post should not be interpreted as a guarantee of any specific outcome. Consult with a qualified healthcare professional for personalized medical advice and treatment. For more information on FDA clearance and product labeling, visit the FDA’s website.

Try StemWave risk free for 60 days

Disclosure Statement: The content provided in this blog post is for informational purposes only and should not be considered medical advice. The opinions expressed are those of medical professionals and are based on a collective analysis of publicly available studies and data. Our company’s product is a Class I medical device, and while it may be related to the topics discussed in this post, it is important to note that our product may not cause similar effects as stated in the post. Additionally, this post should not be interpreted as a guarantee of any specific outcome or result. It’s important to consult with a qualified healthcare professional for personalized medical advice and treatment. We encourage readers to consult the FDA’s website for information on our product’s clearance and any relevant labeling information.

Intended Use Modus-F by StemWave: The Modus-F by StemWave, utilizing Cellular Response Technology, is intended for use in addressing minor aches and pains in accordance with the User Manual (IFU). Use of the product for any other purpose has not been reviewed by the U.S. Food and Drug Administration and is considered off-label use. Please consult the User Manual (IFU) and all labeling provided with the product prior to use.

© 2024 StemWave

Individual results may vary. Neither StemWave nor any of its subsidiaries dispense medical advice. The contents of this website do not constitute medical, legal, or any other type of professional advice. Information related to various health, medical, and fitness conditions and their treatment is not meant to be a substitute for the advice provided by a physician or other medical professional. You should not use the information contained herein for diagnosing a health or fitness problem or disease. Rather, please consult your healthcare professional for information on the courses of treatment, if any, which may be appropriate for you.

Hear patients share their experience with StemWave in their pain treatment journey

Hear from medical providers about StemWave’s impact on their practice and profits

Join our Private Facebook group today!

  • Education & Training
  • Information & Resources
  • Medical Professionals Community

By using our website you agree to our